Literature DB >> 25582622

Ophiopogonin D: A new herbal agent against osteoporosis.

Qiang Huang1, Bo Gao1, Long Wang1, Hong-Yang Zhang1, Xiao-Jie Li1, Jun Shi1, Zheng Wang1, Jin-Kang Zhang2, Liu Yang1, Zhuo-Jing Luo1, Jian Liu3.   

Abstract

Excessive reactive oxygen species (ROS) play an important role in the development of osteoporosis. Ophiopogonin D (OP-D), isolated from the traditional Chinese herbal agent Radix Ophiopogon japonicus, is a potent anti-oxidative agent. We hypothesized that OP-D demonstrates anti-osteoporosis effects via decreasing ROS generation in mouse pre-osteoblast cell line MC3T3-E1 subclone 4 cells and a macrophage cell line RAW264.7 cells. We investigated OP-D on osteogenic and osteoclastic differentiation under oxidative status. Hydrogen peroxide (H2O2) was used to establish an oxidative damage model. In vivo, we established a murine ovariectomized (OVX) osteoporosis model. Then, we searched the molecular mechanism of OP-D against osteoporosis. Our results revealed that OP-D significantly promoted the proliferation of MC3T3-E1 cells and improved some osteogenic markers. Moreover, OP-D reduced TRAP activity and the mRNA expressions of osteoclastic genes in RAW264.7 cells. OP-D suppressed ROS generation in both MC3T3-E1 and RAW264.7 cells. OP-D treatment reduced the activity of serum bone degradation markers, including CTX-1 and TRAP. Further research showed that OP-D displayed anti-osteoporosis effects via reducing ROS through the FoxO3a-β-catenin signaling pathway. In summary, our results indicated that the protective effects of OP-D against osteoporosis are linked to a reduction in oxidative stress via the FoxO3a-β-catenin signaling pathway, suggesting that OP-D may be a beneficial herbal agent in bone-related disorders, such as osteoporosis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FoxO3a; Ophiopogonin D; Osteoclastogenesis; Osteogenesis; Reactive oxygen species; β-Catenin

Mesh:

Substances:

Year:  2015        PMID: 25582622     DOI: 10.1016/j.bone.2015.01.002

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  11 in total

1.  Ophiopogonin D Inhibiting Epithelial NF-κB Signaling Pathway Protects Against Experimental Colitis in Mice.

Authors:  Liang Wang; Huibin Yang; Liang Qiao; Jiani Liu; Xiaoxiao Liao; Huan Huang; Jianyi Dong; Jun Chen; Dapeng Chen; Jingyu Wang
Journal:  Inflammation       Date:  2022-04-23       Impact factor: 4.092

Review 2.  Evolving Roles of Natural Terpenoids From Traditional Chinese Medicine in the Treatment of Osteoporosis.

Authors:  Yue Zhuo; Meng Li; Qiyao Jiang; Hanzhong Ke; Qingchun Liang; Ling-Feng Zeng; Jiansong Fang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-16       Impact factor: 6.055

Review 3.  Role of Traditional Chinese Medicine in Bone Regeneration and Osteoporosis.

Authors:  Zhicai Peng; Ronghua Xu; Qinjian You
Journal:  Front Bioeng Biotechnol       Date:  2022-05-31

4.  Determination of Saponin Content in Hang Maidong and Chuan Maidong via HPLC-ELSD Analysis.

Authors:  Xian-En Li; Yu-Xia Wang; Peng Sun; Deng-Qun Liao
Journal:  J Anal Methods Chem       Date:  2016-01-27       Impact factor: 2.193

5.  Krüppel-like factor 3 inhibition by mutated lncRNA Reg1cp results in human high bone mass syndrome.

Authors:  Mi Yang; Qi Guo; Hui Peng; Yu-Zhong Xiao; Ye Xiao; Yan Huang; Chang-Jun Li; Tian Su; Yun-Lin Zhang; Min-Xiang Lei; Hui-Ling Chen; Tie-Jian Jiang; Xiang-Hang Luo
Journal:  J Exp Med       Date:  2019-06-13       Impact factor: 14.307

Review 6.  Liriopogons (Genera Ophiopogon and Liriope, Asparagaceae): A Critical Review of the Phytochemical and Pharmacological Research.

Authors:  Feiyi Lei; Caroline S Weckerle; Michael Heinrich
Journal:  Front Pharmacol       Date:  2021-12-03       Impact factor: 5.810

Review 7.  Effect of Traditional Chinese Medicine on the Cardiovascular Diseases.

Authors:  Yang Jiang; Qi Zhao; Lin Li; Shumin Huang; Shuai Yi; Zhixi Hu
Journal:  Front Pharmacol       Date:  2022-03-21       Impact factor: 5.810

8.  Human Amnion-Derived Mesenchymal Stem Cells Protect Human Bone Marrow Mesenchymal Stem Cells against Oxidative Stress-Mediated Dysfunction via ERK1/2 MAPK Signaling.

Authors:  Yuli Wang; Junchi Ma; Yifei Du; Jing Miao; Ning Chen
Journal:  Mol Cells       Date:  2016-01-07       Impact factor: 5.034

Review 9.  Bone Health and Natural Products- An Insight.

Authors:  Vasanti Suvarna; Megha Sarkar; Pramila Chaubey; Tabassum Khan; Atul Sherje; Kavitkumar Patel; Bhushan Dravyakar
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

10.  Ophiopogonin D promotes bone regeneration by stimulating CD31hi EMCNhi vessel formation.

Authors:  Mi Yang; Chang-Jun Li; Ye Xiao; Qi Guo; Yan Huang; Tian Su; Xiang-Hang Luo; Tie-Jian Jiang
Journal:  Cell Prolif       Date:  2020-02-20       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.